Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchMedimaps Group S.A. launches next-generation TBS Osteo with FDA approval and MDR certification to enhance fracture risk assessment.
Jan 28, 2025
GenevaManufacturingBiotechnologyData And AnalyticsHealth CareMedicalMedical Device
Product Description
Medimaps Group S.A. has received FDA 510(k) approval and EU MDR certification for its next-generation TBS Osteo software. The enhanced software improves bone microarchitecture assessment and expands connectivity within medical institutions, set to launch across 90 markets worldwide.
Company Information
Company
medimaps group S.A
Location
Geneva, Geneva, Switzerland
About
Medimaps is a leading provider of AI-driven imaging solutions for bone microarchitecture worldwide. Founded by medical professionals and clinical researchers, the company combines Swiss innovation with a global presence to play a leading role in bone health. Their software, TBS Osteo, offers a comprehensive evaluation of bone microarchitecture, assisting healthcare professionals in assessing fracture risks. Medimaps is committed to continuous development to meet the evolving needs of patients and clinicians.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment medimaps group S.A ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.